Fundraising FoxOryzon
1 known investors
Find your way into Oryzon
Sign up to see every warm intro you have to Oryzon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oryzon team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oryzon is a public clinical-stage biopharmaceutical company that uses epigenetics to discover and develop personalized therapies for patients with cancer and central nervous system (CNS) disorders. Its platform identifies and validates biomarkers and therapeutic targets to translate into drug candidates such as vafidemstat and iadademstat.
Investors · 1
Frequently asked questions
- What does Oryzon do?
- Oryzon is a public clinical-stage biopharmaceutical company that uses epigenetics to discover and develop personalized therapies for patients with cancer and central nervous system (CNS) disorders. Its platform identifies and validates biomarkers and therapeutic targets to translate into drug candidates such as vafidemstat and iadademstat.
- Who are Oryzon's investors?
- Oryzon's investors include Inveready Technology Investment Group.